1Coderch L, Fonollosa J, de Rera M,et al.Influence of cholesterol on liposome fluidity by EPR relationship with percutaneous absorption[J]. J Controlled Release,2000,68(3):85.
2Natsuki R,Morita Y,Osava S,et al. Effects of liposome size on penetration of dl-tocopherol acetate into skin[J]. Biol Pharm Bull, 1996, 19(5): 758.
3Coderch L,Perez Cullell N,Estelrich J,et al. The effect of liposomes on skin barrier structure[J]. Skin Pharmacol Appl Skin Physiol. 1999, 12(5):235.
4Sentjure M,Vrhovnik K,Kristl J.Liposomes as a topical delivery system: the role of size on transport studied by the ERP imaging method[J]. J Controlled Release,1999,59:87.
5Hsiu Ying Yu,Hui Min Liao. Triamcinolone permeation from different liposome formulations through rat skin in vitro[J]. Int J Pharma, 1996, 127:1.
6Grit M, Underberg WJM,Crommelin DJA. Hydrolysis of saturated soybean phosphatidycholine in aqueous liposome dispersions[J].J Pharm Sci,1993,82(4):362.
7Sharma BB,Jain SK, Vyas SP. Topical liposomes system bearing local anaeshetic lignocaine : preparation and evaluation[J].J Microcapsual 1994, 11(3):279.
8Short SM,Paasch BD,et al. Percutaneous absorption of biologically-active interferon-gamma in a human skin graft-nude mouse model[J]. Pharm Res, 1996, 13(7): 1020.
9Birchall JC,Marichal C,Campbell L. Gene expression in an intact ex-vivo skin tissue model following percutaneous[J]. Int J Pharm, 2000, 197(1-2): 233.
10Suk-Jae Chung. Future drug delivery research in South Korea[J]. J Controlled Release,1999, (62): 73.
